Description
Leading complex biologics and bioconjugates CDMO+CRO, headquartered in Cambridge (UK) with US operations. 20+ years of experience. Provides end-to-end services for mAbs, ADCs, AOCs, RDCs, fusion proteins, and bispecifics: from antibody discovery and cell line development to clinical and commercial GMP manufacturing. Robust analytical capabilities across all development phases.